Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$754
|
$708B |
14.4x |
36.9x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$154
|
$384B |
4.3x |
12.1x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$179
|
$378B |
6.6x |
14.7x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$79
|
$223B |
3.5x |
8.2x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$294
|
$206B |
6.1x |
10.5x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$449
|
$195B |
4.5x |
17.8x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$169B |
2.7x |
7.0x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$193
|
$153B |
6.4x |
20.2x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$106
|
$148B |
5.1x |
12.4x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$145B |
3.0x |
14.9x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$496
|
$123B |
10.9x |
56.9x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$151
|
$72.0B |
7.8x |
18.2x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$571
|
$56.1B |
3.9x |
10.4x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$151
|
$38.9B |
2.5x |
10.5x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$405
|
$33.5B |
8.5x |
25.3x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$105
|
$31.9B |
4.8x |
16.5x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$240
|
$29.7B |
12.2x |
241.4x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$168
|
$25.2B |
2.5x |
12.6x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$228
|
$24.8B |
1.9x |
11.1x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1083
|
$24.5B |
6.3x |
19.4x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$22.3B |
1.5x |
5.0x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$119
|
$21.7B |
2.3x |
6.5x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$334
|
$21.2B |
7.1x |
19.6x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$32
|
$19.8B |
6.9x |
7.5x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$148
|
$19.3B |
11.0x |
-87.3x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$18.9B |
N/A |
-73.4x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$255
|
$18.4B |
8.4x |
38.1x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$147
|
$14.9B |
1.8x |
8.7x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$98
|
$13.9B |
5.0x |
16.1x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$75
|
$13.3B |
3.1x |
11.3x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$71
|
$12.6B |
32.0x |
-14.3x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$11.1B |
1.7x |
5.7x |
Biomarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$60
|
$10.9B |
3.7x |
16.0x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$44
|
$9.9B |
3.5x |
28.2x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$284
|
$9.8B |
3.3x |
6.2x |
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$131
|
$9.5B |
1.3x |
7.7x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$42
|
$9.4B |
4.7x |
12.8x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$9.3B |
2.3x |
4.9x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$59
|
$9.3B |
2.1x |
21.4x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$36
|
$9.1B |
4.1x |
12.8x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$95
|
$8.8B |
3.6x |
12.8x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$305
|
$8.7B |
4.1x |
18.2x |
Bio-Techne
|
United States of America |
Laboratory Services,
Pharma Diagnostics & Analytics
|
$53
|
$8.5B |
7.0x |
20.2x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$61
|
$8.5B |
8.0x |
12.6x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$8.2B |
1.8x |
9.1x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$107
|
$7.8B |
1.9x |
7.9x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$7.7B |
33.9x |
-13.2x |
Repligen
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$127
|
$7.1B |
10.8x |
57.5x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$67
|
$6.7B |
9.1x |
N/A |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$102
|
$6.7B |
4.3x |
9.6x |
Stevanato Group
|
United States of America |
Medical Supplies,
Drug Delivery Systems
|
$22
|
$6.5B |
5.2x |
21.8x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$25
|
$6.5B |
1.5x |
8.8x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$322
|
$6.3B |
21.4x |
-13.2x |
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$45
|
$6.1B |
7.9x |
-24.5x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$6.0B |
15.2x |
68.8x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$102
|
$5.8B |
2.1x |
-4.5x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$5.3B |
2.4x |
11.4x |
Blueprint Medicines
|
United States of America |
Drug Development & Therapeutics
|
$83
|
$5.1B |
9.0x |
-36.5x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$32
|
$5.1B |
6.9x |
-28.7x |
Sotera Health
|
United States of America |
Laboratory Services,
Medical Supplies
|
$11
|
$5.1B |
4.6x |
9.2x |
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$82
|
$5.0B |
4.5x |
13.5x |
Nomad Foods
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$19
|
$5.0B |
1.5x |
8.4x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$21
|
$4.9B |
11.1x |
27.1x |
RadNet
|
United States of America |
Medical Imaging & Diagnostics,
Laboratory Services
|
$53
|
$4.9B |
2.7x |
17.6x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$104
|
$4.9B |
10.9x |
-22.1x |
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$45
|
$4.9B |
6.2x |
-25.5x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$4.7B |
1.7x |
7.4x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$36
|
$4.6B |
2193.2x |
-6.1x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$4.5B |
182.6x |
-7.9x |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$169
|
$4.3B |
12.7x |
35.0x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$27
|
$4.1B |
1.4x |
-1.1x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$3.9B |
N/A |
-13.3x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$3.9B |
2.6x |
9.7x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$22
|
$3.8B |
N/A |
N/A |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$3.7B |
6.9x |
25.3x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$29
|
$3.7B |
5.3x |
-7.8x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$60
|
$3.6B |
24.9x |
-15.2x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$3.0B |
278.2x |
N/A |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.9B |
71.2x |
N/A |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$60
|
$2.8B |
27.4x |
-18.5x |
Ultragenyx
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$2.7B |
4.6x |
-5.8x |
SpringWorks Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$2.5B |
10.6x |
-10.0x |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$19
|
$2.5B |
3.1x |
-18.2x |
Certara
|
United States of America |
Health Data & Analytics,
Drug Development & Therapeutics
|
$14
|
$2.5B |
6.2x |
19.8x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$32
|
$2.4B |
N/A |
N/A |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$42
|
$2.4B |
63.3x |
-8.8x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$2.4B |
311.6x |
-9.3x |
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$45
|
$2.4B |
7.0x |
15.4x |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$2.3B |
N/A |
-7.5x |
Veracyte
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$32
|
$2.3B |
4.9x |
23.6x |
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$2.3B |
4.5x |
N/A |
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$7
|
$2.3B |
4.0x |
37.9x |
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$2.2B |
5210.3x |
-5.3x |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$10
|
$2.2B |
16.3x |
-2.2x |
Twist Bioscience
|
United States of America |
Genomics & Personalized Medicine,
Bioinformatics
|
$40
|
$2.2B |
6.3x |
-14.8x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$18
|
$2.1B |
N/A |
N/A |
Vericel
|
United States of America |
Regenerative Medicine,
Drug Development & Therapeutics
|
$41
|
$2.0B |
8.2x |
34.7x |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$69
|
$2.0B |
3.0x |
11.9x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$2.0B |
5.4x |
-36.2x |
BioCryst Pharma
|
United States of America |
Drug Development & Therapeutics
|
$7
|
$2.0B |
4.1x |
122.5x |